Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetics of Lung Disease (Exhaled Breath DNA Methylation in Lung Carcinogenesis)

NCT05854563 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT05854563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05854563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetics of Lung Disease (Exhaled Breath DNA Methylation in Lung Carcinogenesis)
Lead sponsor
Albert Einstein College of Medicine
Phase
Observational
Overall status
Recruiting
Start date
March 28, 2023
Completion date
June 30, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung diseases, lung diseases, interstitial, lung diseases, obstructive, lung inflammation